A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 Mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence. LJMHR 2024, 24 (6), 63-87.